Multiple sclerosis: diagnostic issues and modern management
Aim: To provide an insight into the current issues in the diagnosis and management of multiple sclerosis (MS). Methods: A literature-based review was undertaken to determine diagnostic criteria, differential diagnosis, and the use of disease-modifying medication and symptomatic treatments for MS. Th...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
White Rose University Press
2009-08-01
|
Series: | British and Irish Orthoptic Journal |
Subjects: | |
Online Access: | https://www.bioj-online.com/articles/2 |
id |
doaj-77c8821e98094d67bc26efedcda0a6c8 |
---|---|
record_format |
Article |
spelling |
doaj-77c8821e98094d67bc26efedcda0a6c82020-11-24T22:09:53ZengWhite Rose University PressBritish and Irish Orthoptic Journal2516-35902009-08-01651410.22599/bioj.21Multiple sclerosis: diagnostic issues and modern managementSian E. Price0Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, SheffieldAim: To provide an insight into the current issues in the diagnosis and management of multiple sclerosis (MS). Methods: A literature-based review was undertaken to determine diagnostic criteria, differential diagnosis, and the use of disease-modifying medication and symptomatic treatments for MS. The main source of references was Medline via PubMed but standard major reference works on MS were also used. Results: The prevalence of MS may be increasing, especially in women, thereby increasing the need for resources for diagnosis and clinical management of the condition. Clinical diagnosis of MS has changed little since the descriptions of Charcot. However, new diagnostic techniques ranging from neurophysiology and spinal fluid analysis to increasingly sophisticated magnetic resonance imaging have allowed the condition to be diagnosed earlier and with more confidence. New insights in immunology and neuropathology allow differential diagnoses to be excluded and continue to lead to different approaches to managing the condition. New disease-modifying drugs are being used, with the realistic hope of altering the progression of disability. Equally important are new techniques and medications aimed at symptom management, ranging from multidisciplinary team working to drug treatment of pain, fatigue, spasticity, continence and nystagmus. Conclusions: There is continuing improvement in many aspects of the care of people with MS. Insights from epidemiology, genetics, pathology and clinical trials have all contributed to this.https://www.bioj-online.com/articles/2DiagnosisMultiple sclerosisOptic neuritisTreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sian E. Price |
spellingShingle |
Sian E. Price Multiple sclerosis: diagnostic issues and modern management British and Irish Orthoptic Journal Diagnosis Multiple sclerosis Optic neuritis Treatment |
author_facet |
Sian E. Price |
author_sort |
Sian E. Price |
title |
Multiple sclerosis: diagnostic issues and modern management |
title_short |
Multiple sclerosis: diagnostic issues and modern management |
title_full |
Multiple sclerosis: diagnostic issues and modern management |
title_fullStr |
Multiple sclerosis: diagnostic issues and modern management |
title_full_unstemmed |
Multiple sclerosis: diagnostic issues and modern management |
title_sort |
multiple sclerosis: diagnostic issues and modern management |
publisher |
White Rose University Press |
series |
British and Irish Orthoptic Journal |
issn |
2516-3590 |
publishDate |
2009-08-01 |
description |
Aim: To provide an insight into the current issues in the diagnosis and management of multiple sclerosis (MS). Methods: A literature-based review was undertaken to determine diagnostic criteria, differential diagnosis, and the use of disease-modifying medication and symptomatic treatments for MS. The main source of references was Medline via PubMed but standard major reference works on MS were also used. Results: The prevalence of MS may be increasing, especially in women, thereby increasing the need for resources for diagnosis and clinical management of the condition. Clinical diagnosis of MS has changed little since the descriptions of Charcot. However, new diagnostic techniques ranging from neurophysiology and spinal fluid analysis to increasingly sophisticated magnetic resonance imaging have allowed the condition to be diagnosed earlier and with more confidence. New insights in immunology and neuropathology allow differential diagnoses to be excluded and continue to lead to different approaches to managing the condition. New disease-modifying drugs are being used, with the realistic hope of altering the progression of disability. Equally important are new techniques and medications aimed at symptom management, ranging from multidisciplinary team working to drug treatment of pain, fatigue, spasticity, continence and nystagmus. Conclusions: There is continuing improvement in many aspects of the care of people with MS. Insights from epidemiology, genetics, pathology and clinical trials have all contributed to this. |
topic |
Diagnosis Multiple sclerosis Optic neuritis Treatment |
url |
https://www.bioj-online.com/articles/2 |
work_keys_str_mv |
AT sianeprice multiplesclerosisdiagnosticissuesandmodernmanagement |
_version_ |
1725810276352131072 |